This was not unexpected as an association has been previously described between COVID-19 infection causing collapsing glomerulopathy in patients with the high-risk Apolipoprotein L gene 1 (APOL1) polymorphisms, often found in patients of African ethnicity [7]. The gene discussed is APOL1; the disease is lipoprotein glomerulopathy.